Literature DB >> 7961112

Detection of HTLV-II-seropositive blood donors in South Vietnam but not in North Vietnam.

S Yamamoto1, S Nakata, T Nakasone, T Chosa, P Song, D D Duc, B Hien, N X Quang, T N Trinh, T Ono.   

Abstract

Approximately 1% (4/500) of blood donors exhibited seropositivity for HTLV-II in South Vietnam, but none (0/500) did in North Vietnam. Further, all individuals seropositive for HTLV-II were intravenous drug abusers who were seronegative for HIV-1 and HTLV-I. These findings suggest that HTLV-II infection may be specifically prevalent in drug abusers in South Vietnam.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961112      PMCID: PMC5919582          DOI: 10.1111/j.1349-7006.1994.tb02961.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  19 in total

1.  Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis.

Authors:  S Jacobson; T Lehky; M Nishimura; S Robinson; D E McFarlin; S Dhib-Jalbut
Journal:  Ann Neurol       Date:  1993-04       Impact factor: 10.422

2.  Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals.

Authors:  R B Lal; W Heneine; D L Rudolph; W B Present; D Hofhienz; T M Hartley; R F Khabbaz; J E Kaplan
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

3.  Detection of human T lymphotropic virus type II/b in human immunodeficiency virus type 1-coinfected persons in southeastern Italy.

Authors:  M L Calabró; M Luparello; A Grottola; A Del Mistro; J R Fiore; G Angarano; L Chieco-Bianchi
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

4.  Endemic human T cell leukemia virus type II infection in southwestern US Indians involves two prototype variants of virus.

Authors:  B Hjelle; S W Zhu; H Takahashi; S Ijichi; W W Hall
Journal:  J Infect Dis       Date:  1993-09       Impact factor: 5.226

5.  Japanese patients with chronic fatigue syndrome are negative for known retrovirus infections.

Authors:  M Honda; K Kitamura; T Nakasone; Y Fukushima; S Matsuda; K Nishioka; J Matsuda; N Hashimoto; S Yamazaki
Journal:  Microbiol Immunol       Date:  1993       Impact factor: 1.955

6.  Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?

Authors:  R F Khabbaz; D Hartel; M Lairmore; C R Horsburgh; E E Schoenbaum; B Roberts; T M Hartley; G Friedland
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

7.  Multiple isolates and characteristics of human T-cell leukemia virus type II.

Authors:  W W Hall; H Takahashi; C Liu; M H Kaplan; O Scheewind; S Ijichi; K Nagashima; R C Gallo
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA.

Authors:  H H Lee; S H Weiss; L S Brown; D Mildvan; V Shorty; L Saravolatz; A Chu; H M Ginzburg; N Markowitz; D C Des Jarlais
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

9.  Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody.

Authors:  R Fujino; K Kawato; M Ikeda; H Miyakoshi; M Mizukoshi; J Imai
Journal:  Jpn J Cancer Res       Date:  1991-04

10.  Southernmost carriers of HTLV-I/II in the world.

Authors:  L Cartier; F Araya; J L Castillo; V Zaninovic; M Hayami; T Miura; J Imai; S Sonoda; H Shiraki; K Miyamoto
Journal:  Jpn J Cancer Res       Date:  1993-01
View more
  2 in total

1.  Nucleotide sequence variation of human T-lymphotropic virus type II in Vietnam.

Authors:  H Yoshizaki; T Nakasone; T Nakasatomi; S Kusagawa; H Sato; T H Nguyen; H A Mai; T L Hoang; Y Takebe; M Honda
Journal:  Jpn J Cancer Res       Date:  1997-09

2.  Human T-lymphotropic virus type II in Japan.

Authors:  H Yoshizaki; K Kitamura; A Oki; S Yahara; R Yamanaka; Y Fukushima; K Komuro; S Yamazaki; M Honda
Journal:  Jpn J Cancer Res       Date:  1996-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.